| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f70fbcb50a577c8d40360fb9d9c1ad8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 |
| filingDate |
2021-05-06^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6582af6d7cf4b44ca4f5139902c57f5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b0e10da65ff66dfa433e1adaea4cde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc6660afa10fc17490c872180988f1df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71a7b78b66e387871e028ccdaecfd34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0197d6b35e68ae6c0214adf352871989
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8ac1c9854855a58b9980d5bf9ffa836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8ee628c424c5a2ad5518400b051832c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19cd76f762ea39898d251fa7cce0ea7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4a0d5d89d4457a2fd3b6eb7abd8373 |
| publicationDate |
2021-07-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021144478-A2 |
| titleOfInvention |
Combination treatment for fumarate-related diseases |
| abstract |
The present invention relates to a pharmaceutical preparation (combination or pharmaceutical composition or kit-of-parts) comprising one or more dose units of a fumarate compound and an immunogenic or tolerogenic peptide comprising an oxidoreductase motif and an NKT cell epitope or an MHC class II T cell epitope of an (auto)antigen involved in fumarate related diseases or disorders. The present invention further relates to medical uses of this pharmaceutical preparation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11718650-B2 |
| priorityDate |
2020-05-06^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |